Efficacy and safety outcomes of sofosbuvir-based treatment regimens for hepatitis C virus-infected patients with or without cirrhosis from phase III clinical trials.
about
Efficacy and safety outcomes of sofosbuvir-based treatment regimens for hepatitis C virus-infected patients with or without cirrhosis from phase III clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Efficacy and safety outcomes o ...... rom phase III clinical trials.
@en
Efficacy and safety outcomes o ...... rom phase III clinical trials.
@nl
type
label
Efficacy and safety outcomes o ...... rom phase III clinical trials.
@en
Efficacy and safety outcomes o ...... rom phase III clinical trials.
@nl
prefLabel
Efficacy and safety outcomes o ...... rom phase III clinical trials.
@en
Efficacy and safety outcomes o ...... rom phase III clinical trials.
@nl
P2860
P921
P356
P1476
Efficacy and safety outcomes o ...... rom phase III clinical trials.
@en
P2093
Eun Joo Choi
Young-Mo Yang
P2860
P304
P356
10.2147/TCRM.S134818
P577
2017-04-12T00:00:00Z